ciprofloxacin has been researched along with enoxacin in 205 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 102 (49.76) | 18.7374 |
| 1990's | 57 (27.80) | 18.2507 |
| 2000's | 32 (15.61) | 29.6817 |
| 2010's | 12 (5.85) | 24.3611 |
| 2020's | 2 (0.98) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzard, D; Di Cesare, P; Essiz, M; Jacquet, JP; Masuyoshi, M; Oki, T; Remuzon, P; Weber, A | 1 |
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Beikmohammadi, L; Emami, S; Faramarzi, MA; Foroumadi, A; Ghodsi, S; Najjari, S; Samadi, N; Shafiee, A; Shirazi, FH | 1 |
| Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Azéma, J; Dewelle, J; Guidetti, B; Kiss, R; Korolyov, A; Le Calve, B; Malet-Martino, M; Martino, R; Mijatovic, T; Vaysse, J | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gotoh, N; Hayashi, N; Okuda, J; Wakahara, Y | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Allanki, AD; Chandra Shekhar, A; Narsaiah, B; Shanthan Rao, P; Sijwali, PS | 1 |
| Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
| Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
| Ciura, K; Fallarero, A; Fedorowicz, J; Gilbert-Girard, S; Konopacka, A; Lejnowski, D; Morawska, M; Sączewski, J; Savijoki, K; Skok, Ž; Tomašič, T; Waleron, K | 1 |
| Blaskovich, MAT; Pham, TDM; Ziora, ZM | 1 |
| Blumenthal, RM; Burnham, JC; Guan, L | 1 |
| Arai, S; Gohara, Y; Kawashima, T; Kuwano, K; Matsu-Ura, I | 1 |
| Burnham, JC; Guan, L | 1 |
| Jones, RN | 1 |
| Kiyota, H; Mitani, H | 1 |
| Erwin, ME; Jones, RN | 1 |
| Barbé, J; Clerch, B; Llagostera, M | 1 |
| Chidiac, C; Mouton, Y; Senneville, E | 1 |
| Liu, YN; Sun, XD; Wang, R; Zhao, HZ | 1 |
| Cherubin, CE; Eng, RH; Smith, SM; Tan, EN | 1 |
| Kudo, M; Ohkubo, T; Sugawara, K | 1 |
| LeBel, M; Parent, M | 1 |
| Bethune, L; King, A; Phillips, I | 1 |
| Giardina, WJ | 1 |
| Hall, MC; Piddock, LJ; Walters, RN | 1 |
| Barry, AL; Fuchs, PC | 2 |
| Kimura, K; Kise, M; Kitano, M; Matsuda, M; Nishino, T; Otsuki, M; Ozaki, M; Segawa, J; Shibata, K; Tomii, Y | 1 |
| Byl, B; Jacobs, F; Thys, JP | 1 |
| Mnatsakanian, VE; Padeĭskaia, EN | 1 |
| Chuah, SK; Mandal, AK; Thadepalli, CD; Thadepalli, H | 1 |
| Furusawa, M; Iino, T; Marumoto, Y; Nozaki-Renard, J; Ohta, G; Sato, Y | 1 |
| Allen, RA; Amyes, SG; Lewin, CS | 1 |
| Boeckk, M; Borner, K; Deppermann, N; Höffken, G; Koeppe, P; Lode, H | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Barnett, G; Carbó, M; de la Torre, R; Segura, J | 1 |
| Harris, JM | 1 |
| Guzelian, PS; Hunt, C; Karnes, HT; Polk, RE; Sarkar, M | 1 |
| Matsumoto, F; Morita, M; Takahashi, T | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Daschner, F; Kropec, A | 1 |
| Korting, HC; Lukacs, A | 1 |
| Aubert, G; Denis, M; Dorche, G; Loboguerrero, M; Lucht, F; Puech, C | 1 |
| Allen, W; Gorzynski, EA; Gutman, SI | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Smith, RP | 1 |
| Fuhr, U; Harder, S; Staib, AH; Wolff, T | 1 |
| Fong, IW | 1 |
| Dopp, C; Naumann, P | 1 |
| Adam, D; Jäger, A; Kraeft, H; Roos, R | 1 |
| Kashimoto, S; Kojima, T; Kouno, K; Kurobe, N; Minami, A; Nakamura, S; Nakata, K; Ohue, T; Sakaguchi, Y; Yoshida, H | 1 |
| Bedard, J; Bryan, LE | 1 |
| Shah, PM | 2 |
| Harder, S; Papenburg, A; Staib, AH; Stille, W | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
| Neu, HC | 2 |
| Appleman, ME; Gaines, JK; Hadfield, TL; Winn, RE | 1 |
| Hooper, DC; Wolfson, JS | 1 |
| Guimaraes, MA; Noone, P | 1 |
| Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
| Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 2 |
| Foz, A; Roy, C; Segura, C; Teixell, M; Teruel, D; Tirado, M | 1 |
| Edlund, C; Nord, CE | 2 |
| Bailey, J; Heppleston, C; Richmond, SJ | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Smith, SM | 1 |
| Avesani, V; Delmee, M | 1 |
| Kemmerich, B; Pennington, JE; Small, GJ | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Baltch, AL; Bassey, CM; Smith, RP | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Blaser, J; Dudley, MN; Gilbert, D; Zinner, SH | 1 |
| Grimm, H | 2 |
| Høiby, N | 1 |
| Just, G; Shah, PM; Stille, W; Weigand, G | 1 |
| Beer, C; Harder, S; Mieke, S; Shah, P; Staib, AH; Stille, W | 1 |
| Cohen, SP; Hooper, DC; Levy, SB; McMurry, LM; Souza, KS; Wolfson, JS | 1 |
| Davies, S; Sparham, PD; Spencer, RC | 1 |
| Berlin, OG; Bruckner, DA; Young, LS | 1 |
| Kudoh, Y; Matsushita, S; Ohashi, M; Yamada, S | 1 |
| Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
| Verbist, L | 1 |
| Greenwood, D; Muranaka, K | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C; Renaudin, H | 1 |
| Kresken, M; Wiedemann, B | 1 |
| Bremner, DA; Dickie, AS; Singh, KP | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, K | 1 |
| Marks, MI; Parker, KM; Stutman, HR | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Traub, WH | 2 |
| King, A; Phillips, I; Shannon, K | 1 |
| Bailey, J; Heppleston, C; Richmond, S | 1 |
| Chadwick, MV; Gaya, H | 1 |
| Brown, WM; Fallon, RJ | 1 |
| Boscia, JA; Kaye, D; Kobasa, WD | 2 |
| Chin, NX; Neu, HC; Novelli, A | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Finch, R; Martin, J; Pilkington, R | 2 |
| Cattier, B; Gavignet, M; Goudeau, A; Koubaa, N; Quentin, R | 1 |
| Petrou, MA; Rogers, TR | 1 |
| Walker, RC; Wright, AJ | 1 |
| Stolz, E; van der Willigen, AH; Wagenvoort, JH | 1 |
| Claes, J; Pattyn, SR; Valcke, HD; van Caekenberghe, DL; van de Heyning, PH | 1 |
| Beer, C; Frech, K; Harder, S; Mieke, S; Shah, PM; Staib, AH; Stille, W | 2 |
| Andrews, JM; Griggs, D; Lister, D; McNulty, CA; Wise, R | 2 |
| King, A; Phillips, I; Shannon, K; Slegg, J | 1 |
| Rietbrock, N; Staib, AH | 1 |
| King, A; Phillips, I | 1 |
| Dabbs, DJ; Limb, DI; Spencer, RC | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS | 1 |
| Arpi, M; Bentzon, MW; Gahrn-Hansen, B; Søgaard, P | 1 |
| Barry, AL; Jones, RN | 2 |
| Smith, CR | 1 |
| Baars, AM; van Herwaarden, CL; Vree, TB; Wijnands, WJ | 1 |
| Beer, C; Dietlein, G; Harder, S; Mieke, S; Shah, PM; Staib, AH; Stille, W | 1 |
| Dørflinger, T; Gasser, TC; Graversen, PH; Larsen, EH | 1 |
| Akalin, E; Baykal, M | 1 |
| Davies, BI; Maesen, FP | 1 |
| Smith, JT | 1 |
| Eggleston, M; Park, SY | 1 |
| Bannatyne, RM; Cheung, R; Toma, S | 1 |
| Koornhof, HJ; Saunders, J; Shrire, L; Traynor, R | 1 |
| Korrapati, MR; Muppalla, S; Vestal, RE; Wei, X; Zhai, S | 1 |
| Decaris, B; Vandewiele, D; Volff, JN | 1 |
| Cid, D; de la Fuente, R; Garcia, S; Piriz, S; Ruiz-Santa-Quiteria, JA; Vadillo, S; Valle, J | 1 |
| Aarons, L; Davis, JD; Houston, JB | 2 |
| Arman, D; Tural, D; Willke, A | 1 |
| Fujita, H; Matsuo, I | 1 |
| Cho, JK; Han, HJ; Kim, JH; Kim, K; Lee, DS; Park, WB | 1 |
| Iakovlev, VP | 1 |
| Griffiths, NM; Hirst, BH; Simmons, NL | 1 |
| Phillips, I; Power, EG | 1 |
| Mitsuhashi, S; Yoshida, T | 1 |
| Hirano, T; Iseki, K; Kobayashi, M; Miyazaki, K; Miyazaki, S; Sato, I; Sugawara, M; Takada, M | 1 |
| Hale, JA; Knapp, JS; Neal, SW; Rice, RJ; Whittington, WL; Wintersheid, K | 1 |
| Cheung, MM; Ho, NK; Kam, KM; Wong, PW | 1 |
| Fujii, T; Miyazaki, H; Mizuki, Y; Ohmori, H; Yamaguchi, T; Yamamoto, K | 1 |
| Kunze, KL; Parker, BM; Vestal, RE; Wei, X; Zhai, S | 1 |
| Arakane, K; Hirobe, M; Mashiko, S; Nagano, T; Ryu, A; Umezawa, N | 1 |
| Asanuma, A; Iga, T; Kawakami, J; Sawada, Y; Yamamoto, K; Yanagisawa, K | 1 |
| Endo, T; Oda, M; Saitoh, H; Sasaya, M; Takada, M | 1 |
| Iga, T; Kawakami, J; Ohashi, K; Sawada, Y; Yamamoto, K | 1 |
| Fujimura, H; Kohno, K; Niwa, M; Nozaki, M; Uematsu, T | 1 |
| Hostacká, A | 1 |
| Kinzig-Schippers, M; Naber, KG; Sörgel, F; Well, M | 1 |
| Feng, S; Jiang, S; Wang, X | 1 |
| Jensen, KM; Paladino, JA | 1 |
| Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
| Majtán, V; Majtánová, L | 1 |
| Clark, DW; Layton, D; Pearce, GL; Shakir, SA; Wilton, LV | 1 |
| Brewer, PD; Buxton, TB; Farcasiu, D; Hartmann, JF; Herczegh, P; Kovács-Kulyassa, A; McPherson, JC; Plowman, KM; Stroebel, GG; Sztaricskai, F | 1 |
| Schaeffer, AJ | 1 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Chen, L; Huang, JM; Ye, FQ | 1 |
| Ono, C; Tanaka, M | 1 |
| Foroumadi, A; Kiani, Z; Mansouri, S; Rahmani, A | 1 |
| Hong, JW; Hu, CQ; Sheng, LS | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Hatano, K | 1 |
| Alzuet, G; Cantón, E; García-Granda, S; González-Alvarez, M; Jiménez-Garrido, N; Liu-González, M; Ortiz, R; Perelló, L; Pérez-Priede, M | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Espinosa-Mansilla, A; Gómez, DG; Peña, AM; Salinas, F | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Antoniadou-Vyza, E; Michaleas, S | 1 |
| Coombs, GH; Cortázar, TM; Walker, J | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Allen, NS; Lorenzo, F; Navaratnam, S | 1 |
| Cárdenas, YM; Chavez, V; Cordero, T; Fernández, A; Fuentes, A; Hincapie, L; Izzo, C; López, V; Ramirez, AH; Vargas, F; Zoltan, T | 1 |
| Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Kodawara, T; Masada, M; Masuda, S; Matsubara, K; Nakamura, T; Yano, Y | 1 |
| Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O | 1 |
| Fang, G; Gao, J; Gao, X; Li, J; Liu, H; Liu, X; Lu, X; Tang, Y; Wang, J | 1 |
| Arterburn, JB; Azar, SR; Chinnasamy, R; Gass, JT; Hanley, KA; Rossi, SL; Scroggs, SLP; Vasilakis, N; Widen, SG | 1 |
| Beare, PA; Bloom, ME; Broeckel, RM; Flather, DP; Kendall, BL; Morris, CN; Offerdahl, DK; Scroggs, SLP | 1 |
16 review(s) available for ciprofloxacin and enoxacin
| Article | Year |
|---|---|
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Quinolone antibiotics.
Topics: | 2019 |
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro Techniques; Legionnaires' Disease; Ofloxacin; Pefloxacin; Pneumonia, Mycoplasma | 1992 |
Meta-analysis of quinolone-theophylline interactions.
Topics: Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Meta-Analysis as Topic; Quinolones; Theophylline | 1991 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
Topics: Anti-Bacterial Agents; Bacteria; Blood Proteins; Ciprofloxacin; Enoxacin; Fluorine; Humans; Kidney; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding; Quinolines; Urinary Tract Infections | 1985 |
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Topics: Ciprofloxacin; Enoxacin; Humans; Intestines; Naphthyridines; Norfloxacin; Ofloxacin; Oropharynx; Oxazines; Pefloxacin; Quinolines | 1988 |
Symposium on antimicrobial agents. The quinolones.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Humans; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
The use of fluoroquinolones in chronic otitis suppurativa.
Topics: Cholesteatoma; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Enoxacin; Humans; Mastoiditis; Naphthyridines; Otitis Externa; Otitis Media; Otitis Media, Suppurative | 1987 |
Quinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
Review of the 4-quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Enoxacin; Humans; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
[Pharmacokinetics of fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin | 1993 |
The expanding role of fluoroquinolones.
Topics: Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Quinolones; Urinary Tract Infections | 2002 |
11 trial(s) available for ciprofloxacin and enoxacin
| Article | Year |
|---|---|
Comparison of serum bactericidal activity of 4 fluoroquinolones in healthy volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Female; Fluoroquinolones; Gram-Positive Cocci; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Serum Bactericidal Test | 1992 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Dermatitis; Enoxacin; Gram-Negative Bacteria; Humans; Ofloxacin; Osteomyelitis; Pefloxacin | 1989 |
[Bactericidal activity of enoxacin and ciprofloxacin in body fluids].
Topics: Ciprofloxacin; Enoxacin; Escherichia coli; Humans; In Vitro Techniques; Random Allocation; Sputum; Streptococcus pyogenes; Urine | 1989 |
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical Trials as Topic; Enoxacin; Female; Gonorrhea; Humans; Male; Middle Aged; Naphthyridines; Urethritis | 1987 |
The use of fluoroquinolones in chronic otitis suppurativa.
Topics: Cholesteatoma; Chronic Disease; Ciprofloxacin; Clinical Trials as Topic; Enoxacin; Humans; Mastoiditis; Naphthyridines; Otitis Externa; Otitis Media; Otitis Media, Suppurative | 1987 |
[Gyrase inhibitors can delay caffeine elimination].
Topics: Caffeine; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Theophylline | 1986 |
Interaction between quinolones and caffeine.
Topics: Adult; Anti-Infective Agents; Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Quinolines | 1987 |
Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline.
Topics: Adult; Anti-Infective Agents; Bronchodilator Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Protein Binding; Saliva; Theophylline | 1996 |
Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones.
Topics: Adult; Aged; Ciprofloxacin; Cost-Benefit Analysis; Enoxacin; Female; Humans; Injections, Intravenous; Male; Middle Aged | 1997 |
180 other study(ies) available for ciprofloxacin and enoxacin
| Article | Year |
|---|---|
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
Topics: 4-Quinolones; Animals; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Dogs; Gram-Negative Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Staphylococcus; Structure-Activity Relationship | 1989 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship | 2006 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Humans; Maximum Tolerated Dose; Mice; Neoplasms; Piperazine; Piperazines | 2009 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reduced expression of the vca0421 gene of Vibrio cholerae O1 results in innate resistance to ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Fluoroquinolones; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Vibrio cholerae O1 | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Emergence of pyrido quinoxalines as new family of antimalarial agents.
Topics: Antimalarials; Dose-Response Relationship, Drug; Erythrocytes; Humans; Molecular Structure; Plasmodium falciparum; Pyrazines; Quinoxalines; Structure-Activity Relationship | 2014 |
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quaternary Ammonium Compounds; Quinolones; Structure-Activity Relationship | 2019 |
Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
Topics: Anti-Infective Agents; Autoradiography; Bacterial Proteins; Cell Division; Cells, Cultured; Ciprofloxacin; DNA, Bacterial; Enoxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; RNA, Bacterial | 1992 |
[In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Macrolides; Mycoplasma pneumoniae; Norfloxacin; Ofloxacin; Quinolones; Tetracyclines | 1992 |
Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Escherichia coli; Fluoroquinolones; Hemolysin Proteins; Microbial Sensitivity Tests; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
In vitro evaluation of E-4695, a new fluoro-naphthyridine.
Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones | 1992 |
[Influence of new quinolones on superoxide anion generation of polymorphonuclear leukocytes].
Topics: Ciprofloxacin; Enoxacin; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Superoxides | 1992 |
In vitro activity of CP-74667 compared with four other fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Quinolones | 1992 |
The role of the excision and error-prone repair systems in mutagenesis by fluorinated quinolones in Salmonella typhimurium.
Topics: Ciprofloxacin; DNA Repair; Dose-Response Relationship, Drug; Enoxacin; Genes, Bacterial; Genotype; Mutagenesis; Mutagenicity Tests; Mutagens; Ofloxacin; Salmonella typhimurium | 1992 |
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Conformation; Ofloxacin; Respiratory System; Respiratory Tract Infections; Sputum | 1992 |
Determination of ofloxacin in human serum by high-performance liquid chromatography with column switching.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Humans; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Spectrophotometry, Ultraviolet | 1992 |
The in-vitro activity of temafloxacin compared with other antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Species Specificity | 1991 |
Assessment of temafloxacin neurotoxicity in rodents.
Topics: Animals; Anti-Infective Agents; Central Nervous System; Ciprofloxacin; Enoxacin; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxolinic Acid; Phenylbutyrates; Quinolones; Rats; Rats, Inbred Strains; Seizures | 1991 |
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Mutation; Nalidixic Acid; Phenotype; Quinolones; Serratia marcescens; Species Specificity | 1991 |
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus | 1991 |
Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Predictive Value of Tests; Quinolones | 1991 |
In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dogs; Drug Evaluation, Preclinical; Enoxacin; Female; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Piperazines; Prodrugs; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Urinary Tract Infections | 1991 |
[Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Enoxacin; Meningoencephalitis; Mice; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
Antimicrobial activity of intravenous quinolones on the intestinal microflora in dogs.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Colony Count, Microbial; Dogs; Enoxacin; Escherichia coli; Feces; Injections, Intravenous; Jejunum; Norfloxacin; Streptococcus | 1991 |
Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Cell Survival; Ciprofloxacin; Enoxacin; HIV-1; Humans; Lymphocytes; Norfloxacin; Ofloxacin | 1990 |
Antibacterial activity of fluoroquinolones in combination with zidovudine.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Quinolones; Salmonella; Staphylococcus; Zidovudine | 1990 |
Quinolone pharmacokinetics and metabolism.
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Biotransformation; Ciprofloxacin; Enoxacin; Fleroxacin; Half-Life; Humans; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones | 1990 |
Drug interactions affecting theophylline clearance.
Topics: Adolescent; Adult; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Propranolol; Theophylline | 1990 |
In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
Topics: Biotransformation; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Hydroxylation; Microsomes, Liver; Norfloxacin; Theophylline; Uric Acid; Xanthines | 1990 |
[Therapeutic drug monitoring of fluoroquinolone].
Topics: Anti-Infective Agents; Bile; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones; Sputum | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; In Vitro Techniques; Neisseria gonorrhoeae; Penicillin G; Rifampin | 1989 |
[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens | 1989 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Enoxacin; Erythromycin; Imipenem; Legionella; Leucomycins; Microbial Sensitivity Tests; Rifampin | 1989 |
Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
Topics: Adult; Caffeine; Ciprofloxacin; Dealkylation; Drug Interactions; Enoxacin; Humans; Male | 1989 |
[Fluoroquinolones--antibacterial activity, pharmacokinetics and indications for a new group of chemotherapeutic drugs].
Topics: Adult; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Ofloxacin | 1989 |
In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Lung Diseases; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Skin Diseases, Infectious; Urinary Tract Infections | 1989 |
Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Enoxacin; Hydrogen-Ion Concentration; Liposomes; Membranes, Artificial; Phosphatidylcholines; Phospholipids; Solubility | 1989 |
The role of quinolones in staphylococcal infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin; Staphylococcal Infections | 1989 |
[Gyrase inhibitors modify metabolising processes in the liver].
Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors | 1987 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Osteomyelitis; Oxazines; Pefloxacin; Quinolines; Respiratory Tract Infections; Sexually Transmitted Diseases; Surgical Wound Infection; Urinary Tract Infections | 1987 |
Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Whooping Cough | 1987 |
The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
Topics: Acinetobacter; Bacteria; Bacterial Infections; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Quinolines; Serratia; Staphylococcus | 1986 |
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Oxazines; Pneumonia; Quinolines | 1986 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |
[Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1986 |
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Ciprofloxacin; Clostridium; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The action of quinolone carboxylic acids on Chlamydia trachomatis in vitro.
Topics: Animals; Carboxylic Acids; Cells, Cultured; Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Guinea Pigs; Kinetics; Naphthyridines; Ofloxacin; Oxazines; Pneumonia; Pseudomonas Infections; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
In vitro evaluation of A-56619 and A-56620, two new quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Piperazines; Quinolines | 1986 |
Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.
Topics: Anti-Bacterial Agents; Bacteria; Calcium; Ciprofloxacin; Culture Media; Enoxacin; Magnesium; Microbial Sensitivity Tests; Naphthyridines; Pseudomonas aeruginosa; Quinolines | 1986 |
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors | 1985 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
[Resistance against new gyrase inhibitors--1985/86].
Topics: Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Topoisomerase II Inhibitors | 1987 |
Gyrase-inhibitors impair caffeine elimination in man.
Topics: Adult; Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Kinetics; Male; Naphthyridines; Ofloxacin; Oxazines; Topoisomerase II Inhibitors | 1987 |
Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
Topics: Anti-Infective Agents; Biological Transport, Active; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Enoxacin; Escherichia coli; Kinetics; Norfloxacin; Ofloxacin; Spheroplasts | 1988 |
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas | 1986 |
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Naphthyridines; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1987 |
[In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Vibrio cholerae | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines | 1987 |
The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enoxacin; Enterococcus faecalis; Humans; Naphthyridines; Nephelometry and Turbidimetry; Norfloxacin; Urinary Bladder | 1988 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Mycoplasmataceae; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Quinolones; Ureaplasma | 1988 |
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Humans; Nalidixic Acid; Norfloxacin; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1988 |
In-vitro activity of fleroxacin compared with three other quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1988 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Pipemidic Acid; Quinolines; Serratia marcescens | 1985 |
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
Topics: Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Oxazines; Quinolines; Staphylococcus; Streptococcus | 1985 |
Antichlamydial activity of quinolone carboxylic acids.
Topics: Chlamydia trachomatis; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
In vitro activity of ciprofloxacin against mycobacteria.
Topics: Ciprofloxacin; Enoxacin; Mycobacterium; Mycobacterium tuberculosis; Naphthyridines; Quinolines | 1985 |
In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Legionella; Microbial Sensitivity Tests; Mycoplasma; Naphthyridines; Neisseria meningitidis; Quinolines; Staphylococcus aureus | 1985 |
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Cefazolin; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Naphthyridines; Rabbits; Staphylococcal Infections | 1988 |
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Magnesium; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones | 1988 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
In-vitro assessment of lomefloxacin (SC-47111)--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1988 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1988 |
In-vitro activity of antifungal agents in combination with four quinolones.
Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae | 1988 |
The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Half-Life; Humans; Kinetics; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Tissue Distribution | 1986 |
The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Fluoroquinolones; Nalidixic Acid; Naphthyridines; Quinolines; Staphylococcus; Streptococcus | 1986 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
[Gyrase inhibitors: unwanted central nervous system effects].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain Chemistry; Brain Diseases; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Solubility | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
The comparative pharmacokinetics of five quinolones.
Topics: Administration, Oral; Adult; Ciprofloxacin; Enoxacin; Half-Life; Humans; Infusions, Intravenous; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
In-vitro selection of bacteria resistant to the 4-quinolone agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Staphylococcus; Streptococcus | 1987 |
In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Humans; Naphthyridines; Neoplasms; Quinolizines | 1987 |
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Regression Analysis | 1987 |
Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Enterobacter; Enterobacteriaceae Infections; Female; Fluoroquinolones; Naphthyridines; Rabbits | 1987 |
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin | 1987 |
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
The adverse effects of fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Decrease of caffeine elimination in man during co-administration of 4-quinolones.
Topics: Adult; Anti-Infective Agents; Caffeine; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Enoxacin; Half-Life; Humans; Male; Naphthyridines; Ofloxacin; Oxazines; Quinolines | 1987 |
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
Quinolone penetration into canine vaginal and urethral secretions.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Dogs; Enoxacin; Female; Fluoroquinolones; Mucous Membrane; Naphthyridines; Norfloxacin; Quinolines; Urethra; Vagina | 1987 |
[Fluoroquinolones].
Topics: Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Clinical efficacy of the new quinolones in lower respiratory infections.
Topics: Aged; Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pefloxacin; Respiratory Tract Infections; Sputum | 1987 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
Topics: Blood Bactericidal Activity; Ciprofloxacin; Culture Media; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Phagocytosis; Pipemidic Acid; Quinolines; Serratia marcescens; Topoisomerase II Inhibitors | 1984 |
Nalidixic acid analogues and Shigella.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Nalidixic Acid; Naphthyridines; Quinolines; Shigella | 1984 |
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Topics: Anti-Bacterial Agents; Bacteria; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacteriaceae; Nalidixic Acid; Naphthyridines; Norfloxacin; Oxolinic Acid; Pseudomonas aeruginosa; Quinolines | 1984 |
A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Simultaneous determination of theophylline, enoxacin and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Bronchodilator Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Humans; Male; Reproducibility of Results; Saliva; Theophylline | 1995 |
Stimulation of genetic instability and associated large genomic rearrangements in Streptomyces ambofaciens by three fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Enoxacin; Gene Amplification; Gene Deletion; Gene Rearrangement; Genome, Bacterial; Humans; Models, Biological; Mutation; Norfloxacin; Pigmentation; Stimulation, Chemical; Streptomyces | 1994 |
In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Diarrhea, Infantile; Enoxacin; Enrofloxacin; Escherichia coli; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Quinolones; Sheep; Sheep Diseases | 1994 |
Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition.
Topics: Animals; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Theophylline | 1994 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Topics: Absorption; Anti-Infective Agents; Azides; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lipid Peroxidation; Norfloxacin; Ofloxacin; Oxygen; Photochemistry; Photosensitivity Disorders; Quinolones; Sodium Azide; Squalene; Ultraviolet Rays | 1994 |
Dissociation and complexation of fluoroquinolone analogues.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Ferric Compounds; Models, Theoretical; Norfloxacin; Ofloxacin; Spectrophotometry | 1994 |
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Topics: Biological Transport; Carbon Radioisotopes; Cells, Cultured; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Humans; Intestinal Mucosa; Norfloxacin; Ofloxacin; Pefloxacin; Quinolizines | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
Simultaneous assay of fluoroquinolones and theophylline in plasma by high-performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Male; Norfloxacin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Theophylline | 1993 |
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Dioxolanes; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Topoisomerase II Inhibitors | 1993 |
The intestinal transport mechanism of fluoroquinolones: inhibitory effect of ciprofloxacin, an enoxacin derivative, on the membrane potential-dependent uptake of enoxacin.
Topics: Animals; Anti-Infective Agents; Biological Transport, Active; Ciprofloxacin; Enoxacin; Hydrogen-Ion Concentration; Ion Transport; Jejunum; Kinetics; Male; Membrane Potentials; Microvilli; Potassium; Protons; Rats; Rats, Wistar | 1995 |
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Diffusion; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Quinolones | 1995 |
Detection of quinolone-resistant Neisseria gonorrhoeae.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Female; Fleroxacin; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Quinolones; Reference Standards | 1996 |
Intermolecular interactions of antimicrobial fluoroquinolones with purified rat liver CYP1A2 studied by proton nuclear magnetic resonance spectroscopy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Cytochrome P-450 CYP1A2; Enoxacin; Fluoroquinolones; Liver; Magnetic Resonance Spectroscopy; Male; Norfloxacin; Phenacetin; Rats; Rats, Wistar | 1996 |
Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA; DNA Damage; Enoxacin; Fluoroquinolones; Free Radical Scavengers; Hematoporphyrins; Molecular Structure; Ofloxacin; Oxygen; Photosensitizing Agents; Quinolones; Reactive Oxygen Species; Spectroscopy, Near-Infrared; Superoxides | 1997 |
Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Bicuculline; Brain Chemistry; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Synergism; Enoxacin; Female; GABA-A Receptor Antagonists; Injections, Intraventricular; Male; Membrane Potentials; Mice; Microinjections; Norfloxacin; Oocytes; Phenylacetates; Receptors, GABA-A; RNA, Messenger; Seizures; Xenopus laevis | 1997 |
The transport of ciprofloxacin in cultured kidney epithelial cells LLC-PK1.
Topics: Animals; Anti-Infective Agents; Cations; Chromatography, High Pressure Liquid; Ciprofloxacin; Culture Media; Enoxacin; Guanidines; Hydrogen-Ion Concentration; Kidney; LLC-PK1 Cells; Spectrophotometry, Ultraviolet; Swine | 1997 |
Effect of acute renal failure on neurotoxicity of enoxacin in rats.
Topics: Acute Kidney Injury; Animals; Anti-Infective Agents; Brain; Chromatography, High Pressure Liquid; Ciprofloxacin; Convulsants; Enoxacin; Male; Neurons; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet | 1997 |
Role of nitric oxide in the convulsive seizures induced by fluoroquinolones coadministered with 4-biphenyl acetic acid.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Convulsants; Cyclic AMP; Dizocilpine Maleate; Enoxacin; Enzyme Inhibitors; Male; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ofloxacin; Phenylacetates; Seizures | 1997 |
Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Cell Membrane; Ciprofloxacin; Enoxacin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Respiratory System; Surface Properties | 1997 |
Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Topics: Administration, Oral; Adult; Bacteriuria; Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Cross-Over Studies; Enoxacin; Enterococcus faecalis; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Norfloxacin; Proteus mirabilis; Pseudomonas aeruginosa; Random Allocation; Reference Values; Spectrophotometry, Ultraviolet; Time Factors | 1998 |
[Observation of 212 cases of typhoid fever treated with FQNS].
Topics: Adult; Anti-Infective Agents; Child; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Recurrence; Typhoid Fever | 1997 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Movement; Norfloxacin; Serratia marcescens; Virulence | 2000 |
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
Topics: Adult; Aged; Anti-Infective Agents; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Cohort Studies; Databases, Factual; Drug Monitoring; England; Enoxacin; Family Practice; Female; Humans; Liver Diseases; Male; Middle Aged; Norfloxacin; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies; Surveys and Questionnaires; Time Factors | 2001 |
Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials.
Topics: Animals; Anti-Infective Agents; Bone and Bones; Ciprofloxacin; Diphosphonates; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Quinolones; Rats; Spectrometry, Fluorescence; Structure-Activity Relationship; Swine | 2002 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
[Synthesis and antibacterial activity of pyridonecarboxylic acid derivatives containing 2-methyl-5-nitroimidazol].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Combinatorial Chemistry Techniques; Enoxacin; Escherichia coli; Female; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles; Norfloxacin | 2003 |
Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
Topics: Binding Sites; Chloroquine; Ciprofloxacin; Drug Interactions; Enoxacin; Fluoroquinolones; Levodopa; Levofloxacin; Melanins; Monophenol Monooxygenase; Norfloxacin; Ofloxacin; Quinolones; Timolol | 2003 |
Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Microbial Sensitivity Tests; Norfloxacin; Piperazine; Piperazines; Quinolones | 2003 |
[Analysis of the response factors of different quinolones detected by evaporative light-scattering detector].
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Light; Linear Models; Ofloxacin; Quinolones | 2003 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
[Simultaneous determination of quinolones in foods by LC/MS/MS].
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fishes; Fluoroquinolones; Food Analysis; Meat; Ofloxacin; Quinolones; Spectrometry, Mass, Electrospray Ionization | 2004 |
Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin.
Topics: Anti-Infective Agents; Cations; Ciprofloxacin; Cobalt; Copper; Crystallography, X-Ray; DNA; Electrophoresis, Agar Gel; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Molecular Structure; Organometallic Compounds; Oxidation-Reduction; Quinolones | 2005 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Sensitivity and Specificity; Spectrometry, Fluorescence | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
A new approach to quantitative NMR: fluoroquinolones analysis by evaluating the chemical shift displacements.
Topics: Anti-Infective Agents; Ciprofloxacin; Electromagnetic Fields; Enoxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Norfloxacin; Protons; Reproducibility of Results; Solutions; Temperature | 2006 |
Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Cell Line; Cell Nucleus; Ciprofloxacin; Ellagic Acid; Enoxacin; Flavonoids; Fluoroquinolones; Humans; Inhibitory Concentration 50; Leishmania guyanensis; Macrophages; Pentamidine; Quercetin; Topoisomerase II Inhibitors | 2007 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Formation of secondary triplet species after excitation of fluoroquinolones in the presence of relatively strong bases.
Topics: Anti-Infective Agents; Buffers; Ciprofloxacin; Enoxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Oxygen; Photolysis; Solutions; Spectrophotometry; Water | 2008 |
Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivatives.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Enoxacin; Escherichia coli; Fluoroquinolones; Histidine; Hydrogen Peroxide; Hydrogen-Ion Concentration; Luminescence; Naphthalenes; Norfloxacin; Oxidants; Oxidants, Photochemical; Photolysis; Photosensitizing Agents; Reactive Oxygen Species; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Ultraviolet Rays | 2009 |
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures | 2009 |
Inhibitory effect of ciprofloxacin on β-glucuronidase-mediated deconjugation of mycophenolic acid glucuronide.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Enterohepatic Circulation; Glucuronidase; Glucuronides; Immunosuppressive Agents; In Vitro Techniques; Inhibitory Concentration 50; Levofloxacin; Mycophenolic Acid; Ofloxacin; Phenolphthaleins; Time Factors | 2014 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2016 |
Upconversion particle@Fe
Topics: Animals; Biosensing Techniques; Ciprofloxacin; Enoxacin; Enrofloxacin; Erbium; Fishes; Fleroxacin; Fluorescent Dyes; Fluorides; Fluoroquinolones; Levofloxacin; Magnetite Nanoparticles; Molecular Imprinting; Quinolones; Reproducibility of Results; Seafood; Ytterbium; Yttrium | 2018 |
Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.
Topics: Adaptation, Biological; Animals; Antiviral Agents; Biological Evolution; Cell Line; Chlorocebus aethiops; Ciprofloxacin; Dengue; Dengue Virus; Drug Resistance, Viral; Enoxacin; Fluoroquinolones; Genetic Fitness; HEK293 Cells; Host Microbial Interactions; Humans; Mutation; Vero Cells; Viral Envelope; Virus Physiological Phenomena | 2021 |
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
Topics: A549 Cells; Angiotensin-Converting Enzyme 2; Animals; Anti-Bacterial Agents; Antiviral Agents; Cell Line; Chlorocebus aethiops; Ciprofloxacin; Coronavirus Infections; COVID-19 Drug Treatment; Enoxacin; Fluoroquinolones; Humans; Levofloxacin; Middle East Respiratory Syndrome Coronavirus; Moxifloxacin; SARS-CoV-2; Vero Cells | 2020 |